DAFALGAN cpr 500 mg (nouv) 30 pce
7680462060076
CH-46206
N02BE01
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.05 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 11.60
Specialties list
Yes
Generic
No
SL addition date:
01/12/2023
Authorization holder
UPSA Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 46206
- Drug name
- UPSAMOL, Tabletten
- Galenic form
- TAB
- ATC Code
- N02BE01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 17/05/1985
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DAFALGAN cpr 500 mg (nouv) 30 pce
- Description (DE)
- DAFALGAN Tabl 500 mg (neu) 30 Stk
- Market launch
- 17/05/1985
- Narcotic (BTM)
- No